Hyaluronan  ||| S:0 E:11 ||| NNP
Controls  ||| S:11 E:20 ||| NNP
the  ||| S:20 E:24 ||| DT
Deposition  ||| S:24 E:35 ||| NNP
of  ||| S:35 E:38 ||| IN
Fibronectin  ||| S:38 E:50 ||| NNP
and  ||| S:50 E:54 ||| CC
Collagen  ||| S:54 E:63 ||| NNP
and  ||| S:63 E:67 ||| CC
Modulates  ||| S:67 E:77 ||| NNP
TGF-β1  ||| S:77 E:84 ||| NNP
Induction  ||| S:84 E:94 ||| NNP
of  ||| S:94 E:97 ||| IN
Lung  ||| S:97 E:102 ||| NNP
Myofibroblasts  ||| S:102 E:117 ||| NNP
The  ||| S:117 E:121 ||| DT
contribution  ||| S:121 E:134 ||| NN
of  ||| S:134 E:137 ||| IN
hyaluronan-dependent  ||| S:137 E:158 ||| JJ
pericellular  ||| S:158 E:171 ||| JJ
matrix  ||| S:171 E:178 ||| NN
to  ||| S:178 E:181 ||| TO
TGF-β1-driven  ||| S:181 E:195 ||| CD
induction  ||| S:195 E:205 ||| NNS
and  ||| S:205 E:209 ||| CC
maintenance  ||| S:209 E:221 ||| NN
of  ||| S:221 E:224 ||| IN
myofibroblasts  ||| S:224 E:239 ||| NN
is  ||| S:239 E:242 ||| VBZ
not  ||| S:242 E:246 ||| RB
understood ||| S:246 E:256 ||| VBN
.  ||| S:256 E:258 ||| .
Hyaluronan  ||| S:258 E:269 ||| NNP
is  ||| S:269 E:272 ||| VBZ
an  ||| S:272 E:275 ||| DT
extracellular  ||| S:275 E:289 ||| JJ
matrix  ||| S:289 E:296 ||| NNS
( ||| S:296 E:297 ||| -LRB-
ECM ||| S:297 E:300 ||| NNP
)  ||| S:300 E:302 ||| -RRB-
glycosaminoglycan  ||| S:302 E:320 ||| JJ
important  ||| S:320 E:330 ||| JJ
in  ||| S:330 E:333 ||| IN
cell  ||| S:333 E:338 ||| NN
adhesion ||| S:338 E:346 ||| NN
,  ||| S:346 E:348 ||| ,
proliferation  ||| S:348 E:362 ||| NN
and  ||| S:362 E:366 ||| CC
migration ||| S:366 E:375 ||| NN
,  ||| S:375 E:377 ||| ,
and  ||| S:377 E:381 ||| CC
is  ||| S:381 E:384 ||| VBZ
implicated  ||| S:384 E:395 ||| VBN
in  ||| S:395 E:398 ||| IN
myofibroblast  ||| S:398 E:412 ||| JJ
formation  ||| S:412 E:422 ||| NN
and  ||| S:422 E:426 ||| CC
maintenance ||| S:426 E:437 ||| NN
.  ||| S:437 E:439 ||| .
Reduced  ||| S:439 E:447 ||| JJ
turnover  ||| S:447 E:456 ||| NN
of  ||| S:456 E:459 ||| IN
hyaluronan  ||| S:459 E:470 ||| NN
has  ||| S:470 E:474 ||| VBZ
been  ||| S:474 E:479 ||| VBN
linked  ||| S:479 E:486 ||| VBN
to  ||| S:486 E:489 ||| TO
differentiation  ||| S:489 E:505 ||| VB
of  ||| S:505 E:508 ||| IN
myofibroblasts  ||| S:508 E:523 ||| NN
and  ||| S:523 E:527 ||| CC
potentiation  ||| S:527 E:540 ||| NN
of  ||| S:540 E:543 ||| IN
lung  ||| S:543 E:548 ||| NN
fibrosis ||| S:548 E:556 ||| NN
.  ||| S:556 E:558 ||| .
Fibronectin  ||| S:558 E:570 ||| NNP
is  ||| S:570 E:573 ||| VBZ
a  ||| S:573 E:575 ||| DT
fibril  ||| S:575 E:582 ||| NN
forming  ||| S:582 E:590 ||| VBG
adhesive  ||| S:590 E:599 ||| JJ
glycoprotein  ||| S:599 E:612 ||| NN
that  ||| S:612 E:617 ||| WDT
is  ||| S:617 E:620 ||| VBZ
also  ||| S:620 E:625 ||| RB
upregulated  ||| S:625 E:637 ||| VBP
following  ||| S:637 E:647 ||| VBG
induction  ||| S:647 E:657 ||| NN
with  ||| S:657 E:662 ||| IN
TGF-β1 ||| S:662 E:668 ||| CD
.  ||| S:668 E:670 ||| .
Although  ||| S:670 E:679 ||| IN
they  ||| S:679 E:684 ||| PRP
are  ||| S:684 E:688 ||| VBP
known  ||| S:688 E:694 ||| VBN
to  ||| S:694 E:697 ||| TO
bind  ||| S:697 E:702 ||| VB
each  ||| S:702 E:707 ||| DT
other ||| S:707 E:712 ||| JJ
,  ||| S:712 E:714 ||| ,
the  ||| S:714 E:718 ||| DT
interplay  ||| S:718 E:728 ||| NN
between  ||| S:728 E:736 ||| IN
hyaluronan  ||| S:736 E:747 ||| NN
and  ||| S:747 E:751 ||| CC
fibronectin  ||| S:751 E:763 ||| NN
in  ||| S:763 E:766 ||| IN
the  ||| S:766 E:770 ||| DT
pericellular  ||| S:770 E:783 ||| JJ
matrix  ||| S:783 E:790 ||| NN
during  ||| S:790 E:797 ||| IN
myofibroblast  ||| S:797 E:811 ||| JJ
induction  ||| S:811 E:821 ||| NN
and  ||| S:821 E:825 ||| CC
matrix  ||| S:825 E:832 ||| JJ
assembly  ||| S:832 E:841 ||| NN
is  ||| S:841 E:844 ||| VBZ
not  ||| S:844 E:848 ||| RB
clear ||| S:848 E:853 ||| JJ
.  ||| S:853 E:855 ||| .
This  ||| S:855 E:860 ||| DT
study  ||| S:860 E:866 ||| NN
addresses  ||| S:866 E:876 ||| VBZ
the  ||| S:876 E:880 ||| DT
role  ||| S:880 E:885 ||| NN
of  ||| S:885 E:888 ||| IN
hyaluronan  ||| S:888 E:899 ||| NN
and  ||| S:899 E:903 ||| CC
its  ||| S:903 E:907 ||| PRP$
interaction  ||| S:907 E:919 ||| NN
with  ||| S:919 E:924 ||| IN
fibrillar  ||| S:924 E:934 ||| JJ
matrix  ||| S:934 E:941 ||| JJ
components  ||| S:941 E:952 ||| NNS
during  ||| S:952 E:959 ||| IN
myofibroblast  ||| S:959 E:973 ||| JJ
formation ||| S:973 E:982 ||| NN
.  ||| S:982 E:984 ||| .
Hyaluronan  ||| S:984 E:995 ||| NNP
and  ||| S:995 E:999 ||| CC
fibronectin  ||| S:999 E:1011 ||| NNS
were  ||| S:1011 E:1016 ||| VBD
increased  ||| S:1016 E:1026 ||| VBN
and  ||| S:1026 E:1030 ||| CC
co-localized  ||| S:1030 E:1043 ||| JJ
in  ||| S:1043 E:1046 ||| IN
the  ||| S:1046 E:1050 ||| DT
ECM  ||| S:1050 E:1054 ||| NNP
following  ||| S:1054 E:1064 ||| VBG
myofibroblast  ||| S:1064 E:1078 ||| JJ
induction  ||| S:1078 E:1088 ||| NN
by  ||| S:1088 E:1091 ||| IN
TGF-β1 ||| S:1091 E:1097 ||| CD
.  ||| S:1097 E:1099 ||| .
Inhibition  ||| S:1099 E:1110 ||| NNP
of  ||| S:1110 E:1113 ||| IN
hyaluronan  ||| S:1113 E:1124 ||| JJ
synthesis  ||| S:1124 E:1134 ||| NN
in  ||| S:1134 E:1137 ||| IN
TGF-β1-induced  ||| S:1137 E:1152 ||| CD
lung  ||| S:1152 E:1157 ||| NN
myofibroblasts  ||| S:1157 E:1172 ||| NN
over  ||| S:1172 E:1177 ||| IN
a  ||| S:1177 E:1179 ||| DT
4day  ||| S:1179 E:1184 ||| JJ
period  ||| S:1184 E:1191 ||| NN
with  ||| S:1191 E:1196 ||| IN
4-methyl  ||| S:1196 E:1205 ||| CD
umbelliferone  ||| S:1205 E:1219 ||| NNS
( ||| S:1219 E:1220 ||| -LRB-
4-MU ||| S:1220 E:1224 ||| NNP
)  ||| S:1224 E:1226 ||| -RRB-
further  ||| S:1226 E:1234 ||| RB
enhanced  ||| S:1234 E:1243 ||| VBN
myofibroblast  ||| S:1243 E:1257 ||| JJ
morphology ||| S:1257 E:1267 ||| NN
,  ||| S:1267 E:1269 ||| ,
caused  ||| S:1269 E:1276 ||| VBD
increased  ||| S:1276 E:1286 ||| VBN
deposition  ||| S:1286 E:1297 ||| VBN
of  ||| S:1297 E:1300 ||| IN
fibronectin  ||| S:1300 E:1312 ||| NN
and  ||| S:1312 E:1316 ||| CC
type  ||| S:1316 E:1321 ||| NN
I  ||| S:1321 E:1323 ||| PRP
collagen  ||| S:1323 E:1332 ||| VBD
in  ||| S:1332 E:1335 ||| IN
the  ||| S:1335 E:1339 ||| DT
ECM ||| S:1339 E:1342 ||| NNP
,  ||| S:1342 E:1344 ||| ,
and  ||| S:1344 E:1348 ||| CC
increased  ||| S:1348 E:1358 ||| JJ
expression  ||| S:1358 E:1369 ||| NN
of  ||| S:1369 E:1372 ||| IN
alpha-smooth  ||| S:1372 E:1385 ||| JJ
muscle  ||| S:1385 E:1392 ||| NN
actin  ||| S:1392 E:1398 ||| NNS
and  ||| S:1398 E:1402 ||| CC
hyaluronan  ||| S:1402 E:1413 ||| CD
synthase  ||| S:1413 E:1422 ||| CD
2  ||| S:1422 E:1424 ||| CD
( ||| S:1424 E:1425 ||| -LRB-
HAS2 ||| S:1425 E:1429 ||| NNP
)  ||| S:1429 E:1431 ||| -RRB-
mRNA ||| S:1431 E:1435 ||| JJ
.  ||| S:1435 E:1437 ||| .
Hyaluronan  ||| S:1437 E:1448 ||| JJ
oligosaccharides  ||| S:1448 E:1465 ||| NN
or  ||| S:1465 E:1468 ||| CC
hyaluronidase  ||| S:1468 E:1482 ||| JJ
treatment ||| S:1482 E:1491 ||| NN
,  ||| S:1491 E:1493 ||| ,
which  ||| S:1493 E:1499 ||| WDT
more  ||| S:1499 E:1504 ||| RBR
effectively  ||| S:1504 E:1516 ||| RB
disrupted  ||| S:1516 E:1526 ||| VBN
the  ||| S:1526 E:1530 ||| DT
pericellular  ||| S:1530 E:1543 ||| JJ
matrix ||| S:1543 E:1549 ||| NN
,  ||| S:1549 E:1551 ||| ,
had  ||| S:1551 E:1555 ||| VBD
similar  ||| S:1555 E:1563 ||| JJ
effects ||| S:1563 E:1570 ||| NNS
.  ||| S:1570 E:1572 ||| .
CD44  ||| S:1572 E:1577 ||| NNP
and  ||| S:1577 E:1581 ||| CC
β1  ||| S:1581 E:1584 ||| CD
integrins  ||| S:1584 E:1594 ||| JJ
co-localized  ||| S:1594 E:1607 ||| NN
in  ||| S:1607 E:1610 ||| IN
the  ||| S:1610 E:1614 ||| DT
cell  ||| S:1614 E:1619 ||| NN
membrane  ||| S:1619 E:1628 ||| NNS
and  ||| S:1628 E:1632 ||| CC
along  ||| S:1632 E:1638 ||| IN
some  ||| S:1638 E:1643 ||| DT
stress  ||| S:1643 E:1650 ||| NN
fibers ||| S:1650 E:1656 ||| NNS
.  ||| S:1656 E:1658 ||| .
However ||| S:1658 E:1665 ||| RB
,  ||| S:1665 E:1667 ||| ,
CD44  ||| S:1667 E:1672 ||| NNP
and  ||| S:1672 E:1676 ||| CC
hyaluronan  ||| S:1676 E:1687 ||| NNS
were  ||| S:1687 E:1692 ||| VBD
specifically  ||| S:1692 E:1705 ||| RB
excluded  ||| S:1705 E:1714 ||| VBN
from  ||| S:1714 E:1719 ||| IN
focal  ||| S:1719 E:1725 ||| JJ
adhesions ||| S:1725 E:1734 ||| NN
,  ||| S:1734 E:1736 ||| ,
and  ||| S:1736 E:1740 ||| CC
associated  ||| S:1740 E:1751 ||| VBN
primarily  ||| S:1751 E:1761 ||| RB
with  ||| S:1761 E:1766 ||| IN
cortical  ||| S:1766 E:1775 ||| JJ
actin ||| S:1775 E:1780 ||| NN
.  ||| S:1780 E:1782 ||| .
Time-lapse  ||| S:1782 E:1793 ||| JJ
imaging  ||| S:1793 E:1801 ||| NN
of  ||| S:1801 E:1804 ||| IN
the  ||| S:1804 E:1808 ||| DT
immediate  ||| S:1808 E:1818 ||| JJ
effects  ||| S:1818 E:1826 ||| NNS
of  ||| S:1826 E:1829 ||| IN
hyaluronidase  ||| S:1829 E:1843 ||| JJ
digestion  ||| S:1843 E:1853 ||| NN
showed  ||| S:1853 E:1860 ||| VBD
that  ||| S:1860 E:1865 ||| DT
hyaluronan  ||| S:1865 E:1876 ||| JJ
matrix  ||| S:1876 E:1883 ||| NNS
primarily  ||| S:1883 E:1893 ||| RB
mediates  ||| S:1893 E:1902 ||| JJ
attachment  ||| S:1902 E:1913 ||| NN
of  ||| S:1913 E:1916 ||| IN
membrane  ||| S:1916 E:1925 ||| NN
and  ||| S:1925 E:1929 ||| CC
cortical  ||| S:1929 E:1938 ||| JJ
actin  ||| S:1938 E:1944 ||| NN
between  ||| S:1944 E:1952 ||| IN
focal  ||| S:1952 E:1958 ||| JJ
contacts ||| S:1958 E:1966 ||| NNS
,  ||| S:1966 E:1968 ||| ,
suggesting  ||| S:1968 E:1979 ||| VBG
that  ||| S:1979 E:1984 ||| DT
surface  ||| S:1984 E:1992 ||| NN
adhesion  ||| S:1992 E:2001 ||| NN
through  ||| S:2001 E:2009 ||| IN
hyaluronan  ||| S:2009 E:2020 ||| NN
and  ||| S:2020 E:2024 ||| CC
CD44  ||| S:2024 E:2029 ||| NNP
is  ||| S:2029 E:2032 ||| VBZ
distinct  ||| S:2032 E:2041 ||| VBN
from  ||| S:2041 E:2046 ||| IN
focal  ||| S:2046 E:2052 ||| JJ
adhesion  ||| S:2052 E:2061 ||| NN
through  ||| S:2061 E:2069 ||| IN
β1  ||| S:2069 E:2072 ||| CD
integrins  ||| S:2072 E:2082 ||| NNS
and  ||| S:2082 E:2086 ||| CC
fibronectin ||| S:2086 E:2097 ||| NN
.  ||| S:2097 E:2099 ||| .
Fluorescein-labeled  ||| S:2099 E:2119 ||| JJ
hyaluronan  ||| S:2119 E:2130 ||| NNS
bound  ||| S:2130 E:2136 ||| VBN
regularly  ||| S:2136 E:2146 ||| RB
along  ||| S:2146 E:2152 ||| IN
fibronectin  ||| S:2152 E:2164 ||| JJ
fibers  ||| S:2164 E:2171 ||| NNS
and  ||| S:2171 E:2175 ||| CC
co-localized  ||| S:2175 E:2188 ||| JJ
more  ||| S:2188 E:2193 ||| JJR
with  ||| S:2193 E:2198 ||| IN
β1  ||| S:2198 E:2201 ||| CD
integrin  ||| S:2201 E:2210 ||| NNS
and  ||| S:2210 E:2214 ||| CC
less  ||| S:2214 E:2219 ||| JJR
with  ||| S:2219 E:2224 ||| IN
CD44 ||| S:2224 E:2228 ||| CD
.  ||| S:2228 E:2230 ||| .
Therefore ||| S:2230 E:2239 ||| RB
,  ||| S:2239 E:2241 ||| ,
the  ||| S:2241 E:2245 ||| DT
hyaluronan  ||| S:2245 E:2256 ||| JJ
matrix  ||| S:2256 E:2263 ||| NN
can  ||| S:2263 E:2267 ||| MD
interfere  ||| S:2267 E:2277 ||| VB
with  ||| S:2277 E:2282 ||| IN
the  ||| S:2282 E:2286 ||| DT
assembly  ||| S:2286 E:2295 ||| NN
of  ||| S:2295 E:2298 ||| IN
fibrillar  ||| S:2298 E:2308 ||| JJ
ECM  ||| S:2308 E:2312 ||| NN
components ||| S:2312 E:2322 ||| NNS
,  ||| S:2322 E:2324 ||| ,
and  ||| S:2324 E:2328 ||| CC
this  ||| S:2328 E:2333 ||| DT
interplay  ||| S:2333 E:2343 ||| NN
regulates  ||| S:2343 E:2353 ||| VBZ
the  ||| S:2353 E:2357 ||| DT
degree  ||| S:2357 E:2364 ||| NN
of  ||| S:2364 E:2367 ||| IN
myofibroblast  ||| S:2367 E:2381 ||| JJ
formation ||| S:2381 E:2390 ||| NN
.  ||| S:2390 E:2392 ||| .
These  ||| S:2392 E:2398 ||| DT
data  ||| S:2398 E:2403 ||| NNS
also  ||| S:2403 E:2408 ||| RB
suggest  ||| S:2408 E:2416 ||| VB
that  ||| S:2416 E:2421 ||| DT
adhesion  ||| S:2421 E:2430 ||| NN
through  ||| S:2430 E:2438 ||| IN
hyaluronan  ||| S:2438 E:2449 ||| FW
matrix  ||| S:2449 E:2456 ||| FW
impacts  ||| S:2456 E:2464 ||| FW
cytoskeletal  ||| S:2464 E:2477 ||| FW
organization ||| S:2477 E:2489 ||| NN
,  ||| S:2489 E:2491 ||| ,
and  ||| S:2491 E:2495 ||| CC
is  ||| S:2495 E:2498 ||| VBZ
potentially  ||| S:2498 E:2510 ||| RB
part  ||| S:2510 E:2515 ||| NN
of  ||| S:2515 E:2518 ||| IN
a  ||| S:2518 E:2520 ||| DT
clutch  ||| S:2520 E:2527 ||| JJ
mechanism  ||| S:2527 E:2537 ||| NN
that  ||| S:2537 E:2542 ||| WDT
regulates  ||| S:2542 E:2552 ||| VBZ
stick  ||| S:2552 E:2558 ||| VBN
and  ||| S:2558 E:2562 ||| CC
slip  ||| S:2562 E:2567 ||| NN
of  ||| S:2567 E:2570 ||| IN
myofibroblasts  ||| S:2570 E:2585 ||| NN
by  ||| S:2585 E:2588 ||| IN
affecting  ||| S:2588 E:2598 ||| VBG
the  ||| S:2598 E:2602 ||| DT
adhesion  ||| S:2602 E:2611 ||| NN
to  ||| S:2611 E:2614 ||| TO
and  ||| S:2614 E:2618 ||| CC
organization  ||| S:2618 E:2631 ||| NN
of  ||| S:2631 E:2634 ||| IN
fibronectin  ||| S:2634 E:2646 ||| NN
and  ||| S:2646 E:2650 ||| CC
collagen ||| S:2650 E:2658 ||| NN
.  ||| S:2658 E:2660 ||| .
